FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/05/014106 [Registered on: 25/05/2018] Trial Registered Prospectively
Last Modified On: 06/07/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Other (Specify) [Compare efficacy of TXA in two route of administration]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare the effect of use of both intravenous and intra articular injection of tranexamic acid with only intra-articular injection of tranexamic acid in reducing blood loss in total knee replacement patients in western india  
Scientific Title of Study   To compare the efficacy of combined use of intravenous and Intra-articular injection of Tranexamic acid with intra-articular administration alone in reducing blood loss in Primary Total Knee Arthroplasty: Randomized controlled trial  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Yeshi Dorji 
Designation  PG STUDENT 
Affiliation  Armed Forces Medical College 
Address  Department Of Orthopedics Golden Jubilee Block Armed Forces Medical College pune

Pune
MAHARASHTRA
411040
India 
Phone  7264069572  
Fax    
Email  dorjiyeshi5@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anil Kumar Mishra 
Designation  Professor 
Affiliation  Armed Forces Medical College 
Address  Department Of Orthopedics Golden Jubilee Block Armed Forces Medical College pune

Pune
MAHARASHTRA
411040
India 
Phone  7875443895  
Fax    
Email  anilortho2@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Yeshi Dorji 
Designation  PG STUDENT 
Affiliation  Armed Forces Medical College 
Address  Department Of Orthopedics Golden Jubilee Block Armed Forces Medical College pune

Pune
MAHARASHTRA
411040
India 
Phone  7264069572  
Fax    
Email  dorjiyeshi5@gmail.com  
 
Source of Monetary or Material Support  
LT(Dr) Yeshi Dorji PG student Dept of orthopedics Golden Jubilee Block Armed Forces Medical College pune 
 
Primary Sponsor  
Name  Yeshi Dorji 
Address  Dept of Orthopedics Golden Jubilee Block Armed Forces Medical College pune 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Yeshi Dorji  command hospital,pune  Dept of orthopedics Golden Jubilee Block Armed Forces Medical college pune
Pune
MAHARASHTRA 
00917264069572

dorjiyeshi5@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Medical research cell & institutional ethical committee,Armed forces medical college,pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  All patients who are undergoing primary TKA, (1) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not applicable  Not applicable 
Intervention  Tranexamic acid-intravenous and intra-articular combined vs intra-articular injection alone  Intervention is to give both intravenous and intra-articular TXA to one group of patients who are undergoing primary TKA Compare with only intra-articular injection alone group and find out the differences of amount of blood loss in primary TKA patient post operatively 
 
Inclusion Criteria  
Age From  50.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  In combined Group-1gm of TXA using I.V injection 15 mins before skin incision and 1gm of TXA using intra-articular intra operatively after closure of joint capsule in primary TKA
Single group-Receives only 1gm of TXA intra-articular intraoperatively after joint capsule closure in primary TKA.
 
 
ExclusionCriteria 
Details  Patient unwilling for study-no consent
Patients allergic to TXA
Patient with known history of thromboembolic disease
Patients with cardiovascular disease like MI
Patients with history of cerebral vascular disease- stroke
pre op renal dysfunction
pre op coagulopathy plt less than 1.5lakh and INR more than 1.4  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Compare Fall in Haemoglobin level,haematocrit and Drain output   post operative day Hb level on day 3, day 5 and day 14
Drain output is measured after 24 hours post surgery 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the amount of blood loss with combined (intravenous and intra-articular) TXA in primary TKA
To evaluate amount of blood loss with only intra-articular administration of TXA in primary TKA 
Post operative day1,3,5 & 14 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "31"
Final Enrollment numbers achieved (India)="31" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   01/06/2018 
Date of Study Completion (India) 28/06/2019 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="1" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not yet published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   To compare the efficacy of combined group(I.V and intra-articular) vs single group(intra-articular only) in reducing post operative blood loss in primary TKA patients
1gm of TXA is given I.V 15 mins before skin incision and Intra-articular injection is given after closure of joint capsule
Post operatively Heamoglobin and Haematocrit are evaluated on day 3, day5 and day 14
Drain output is measured after 24 hours post operative

Then blood loss of two groups are compared with data collected as mentioned above
 
Close